HOYA company profile
Company profile
HOYA has 37,752 employees and is headquartered in Shinjuku, Japan.
Life Care, the first of the two segments, covers eyeglasses and contact lenses, medical endoscopes, intraocular lenses, and laparoscopic surgical instruments, along with endoscope cleaning equipment and implant-related materials for orthopedics, neurosurgery and dentistry. Through its Eyecity chain it also sells contact lenses directly at retail. The Information and Communications segment supplies mask blanks and photomasks for semiconductor chips and flat panel displays, glass disks for hard disk drives, and optical glass and lenses. The group sells across Japan, Asia, the Americas, Europe and other regions.
In the fiscal year ended March 31, 2026, HOYA reported revenue of 947.7 billion yen, up 9.4% from the previous year, and net income of 253.1 billion yen. The company was founded in 1941 and is headquartered in Shinjuku, Japan, with 37,752 employees.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Japan
- Headquarters
- Nittochi Nishishinjuku Building, 160-8347, Shinjuku
- Employees
- 37,752
- Chief executive
- Eiichiro Ikeda
- Founded
- 1941
- Fiscal year
- April - March
- Listing
- 7741 · TSE
- Indices
- Nikkei 225
- Currency
- JPY
- ISIN
- JP3837800006
- Website
- hoya.com
HOYA and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| HOYA7741 | Japan | $49.59B | 37,752 | 34.4% | 28.7 |
| Resmed CdiRMD | Australia | $33.37B | 11,370 | 34.0% | 21.7 |
| Fisher And Paykel Healthcare CorpoFPH | Australia | $15.77B | 7,357 | 27.6% | 55.6 |
| Lenskart SolutionsLENSKART | India | $13.36B | 19,201 | 10.5% | 161.2 |
| AnsellANN | Australia | $4.42B | 15,000 | 15.0% | 21.9 |
| MedlineMDLN | United States | $51.94B | 45,000 | 5.4% | 89.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
